Hannah Zierden
Hannah Zierden
Dr. Zierden is an Assistant Professor in the Chemical and Biomolecular Engineering Department at UMD. Dr. Zierden graduated from The Ohio State University with a B.S. in Chemical and Biomolecular Engineering. While at OSU, she performed research under the guidance of Dr. David Wood, investigating efficient methods of protein purification. She then joined the ChBE program at Johns Hopkins University, where she earned her Ph.D. under the supervision of Drs. Laura Ensign and Justin Hanes in the Center for Nanomedicine. Her thesis focused on improving vaginal drug delivery during pregnancy, and the resulting work highlighted the need for effective drug delivery in order to understand drug action in the context of disease. In order to better understand biological mechanisms, and master the tools necessary to probe these questions, Dr. Zierden joined the laboratory of Dr. Tracy Bale as a postdoctoral researcher. In the Bale Lab, Dr. Zierden studied how extracellular vesicles from the placenta aid in maternal-fetal communication, and how these biological nanoparticles may play a role in pregnancy outcomes. The Zierden Lab combines these experiences by asking how extracellular vesicles from the maternal vaginal microbiome communicate with the host to dictate both maternal and fetal health outcomes, and how these particles may be used as therapeutics in a wide range of human disease.
Latest Papers
Vaginal bacteria-derived extracellular vesicles diffuse through human cervicovaginal mucus to enable bacterial signaling to upper female reproductive tract tissues
Author(s): Darby Steinman, Alyssa Petersen, Yasmi Chibber, et. al
UMD Author(s): Hannah Zierden
Locally administered nanosuspension increases delivery of estradiol for the treatment of vaginal atrophy in mice
|
Drug Delivery and Translational Research
Author(s): Rachel L. Shapiro, Titania Bethiana, Davell M. Carter, et. al
UMD Author(s): Hannah Zierden
Microorganism-derived extracellular vesicles: emerging contributors to female reproductive health
|
Nanoscale
Author(s): Kaitlyn A. Moore, Alyssa P. Petersen, Hannah C. Zierden
UMD Author(s): Hannah Zierden
Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome.
|
Frontiers in cellular and infection microbiology
Author(s): Zierden HC, DeLong K, Zulfiqar F, et. al
UMD Author(s): Hannah Zierden
Extracellular vesicles are dynamic regulators of maternal glucose homeostasis during pregnancy.
|
Scientific Reports
Author(s): Zierden HC, Marx-Rattner R, Rock KD, et. al
UMD Author(s): Hannah Zierden
Next generation strategies for preventing preterm birth.
|
Advanced drug delivery reviews
Author(s): Zierden HC, Shapiro RL, DeLong K, et. al
UMD Author(s): Hannah Zierden
Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth
|
Science Translational Medicine
Author(s): Hannah C. Zierden, Jairo I. Ortiz, Kevin DeLong, et. al
UMD Author(s): Hannah Zierden
Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.
|
Trends in Molecular Medicine
Author(s): Zierden HC, Josyula A, Shapiro RL, et. al
UMD Author(s): Hannah Zierden
Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth.
|
Science Translational Medicine
Author(s): Zierden HC, Ortiz JI, DeLong K, et. al
UMD Author(s): Hannah Zierden
The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
|
PLoS pathogens
UMD Author(s): Hannah Zierden